Schrödinger, Inc. (NASDAQ:SDGR) is one of the best healthcare AI stocks to buy now. On December 15, BofA Securities upgraded ...
Earlier in December 2025, BofA Securities upgraded Schrödinger, Inc. after the company shifted away from internal drug development to concentrate on its core computational software business. This ...
A project to improve data visualization ended up overturning a century-old model of color space that underpins industry standards for color everywhere from digital displays to paint. The opportunity ...
Schrodinger is a biotech company that uses machine learning, physics, and chemistry to speed up the drug discovery process, focusing on finding ligands that bind with proteins to treat diseases. The ...
Hosted on MSN
Schrodinger Downgraded By Citi After Ending Blood Cancer Drug Trial Tied To 2 Deaths; Retail Voices Concern
Schrodinger shares came under pressure after Citi pulled back its bullish call, cutting the stock to ‘Neutral’ from ‘Buy’ and slashing its price target to $20 from $35. The firm said recent stumbles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback